Share this article on:

Selected Reports From the 2009 Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September 2009, and the Annual Meeting of the Infectious Diseases Society of America, Philadelphia, October 2009

File, Thomas MD

Infectious Diseases in Clinical Practice: January 2010 - Volume 18 - Issue 1 - p 5-6
doi: 10.1097/IPC.0b013e3181cada86
IDC Snapshots

Dr File discloses that he has received recent research funding from Cerexa, Ortho-McNeil, Protez, Rib-X, and Pfizer and Boehringer Ingelheim, Gilead, and Tibotec and is a consultant for Cerexa/Forest, Ortho-McNeil, Protez, Merck, Nabriva, and Pfizer.

© 2010 Lippincott Williams & Wilkins, Inc.